Literature DB >> 6476208

Donovanosis affecting cervix, uterus, and adnexae.

S K Sengupta, N Das.   

Abstract

Donovanosis (granuloma inguinale), a disease often related to sexual contact, has been a clinical problem in Papua New Guinea for more than 9 decades. It is a common cause of anogenital lesions in females in this country. Lesions on the cervix or vaginal vault, and extension of the disease process from the external genitalia to the uterus, tubes and ovaries, are thought to be rare. In this study an attempt was made to discover the frequency of involvement of cervix, uterus and adnexae, with or without external genital involvement, by retrospectively analyzing the histological and clinical records of patients with anogenital donovanosis for a period of 8 years (1975-1982). In 35 of 351 patients (10%), donovanosis involved the cervix. The clinical profile of these cases, certain unusual features in a few cases, and the pathological findings are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6476208     DOI: 10.4269/ajtmh.1984.33.632

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  Granuloma inguinale of the cervix: a carcinoma look-alike.

Authors:  A A Hoosen; G Draper; J Moodley; K Cooper
Journal:  Genitourin Med       Date:  1990-10

2.  The dark side to Donovanosis: color, climate, race and racism in American South venereology.

Authors:  Lawrence Hammar
Journal:  J Med Humanit       Date:  1997

3.  Ceftriaxone in the treatment of chronic donovanosis in central Australia.

Authors:  A Merianos; M Gilles; J Chuah
Journal:  Genitourin Med       Date:  1994-04

Review 4.  The diagnosis and treatment of donovanosis (granuloma inguinale).

Authors:  J Richens
Journal:  Genitourin Med       Date:  1991-12

Review 5.  The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis.

Authors:  Andrew Vallely; Andrew Page; Shannon Dias; Peter Siba; Tony Lupiwa; Greg Law; John Millan; David P Wilson; John M Murray; Michael Toole; John M Kaldor
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.